On March 23, Baiyunshan signed two “big orders†for medical equipment and big health, and will jointly establish “International Medical Device R&D Incubation Industry Platform†with Guangzhou Aoida Medical Device Technology Co., Ltd.; The subsidiary company Guangzhou Wang Lao Ji Da Health Industry Co., Ltd. and Shanxi Dazhai Beverage Co., Ltd. will establish a joint venture company controlled by Wang Lao Ji Da Health Company to produce and operate the “Dazhai†brand walnut dew and series products.
Layout medical device industry
The data shows that the average annual growth rate of medical devices and diagnostic reagents is more than 25%, which is higher than the growth of the pharmaceutical industry. At present, the scale of China's medical device market only accounts for about 13% of the pharmaceutical industry, far below the level of 50% in Europe and America, and the market potential is huge.
AOSTA is a medical device clinical trial CRO and medical device integrated service provider. The signing of the contract, the two sides will give full play to the resource advantages of capital, product technology, market, etc., and carry out extensive cooperation in the introduction, research and development, and sales of medical devices, including the establishment of the "International Medical Device R&D Incubation Industry Platform" and the establishment of medical devices. A cluster of strategic emerging industries and a joint venture with the Baiyunshan Oswego Medical Devices and Translational Medicine Research Institute. At the same time, it will use Baiyunshan's sales channels to promote project development, product manufacturing and high-end product output for innovative medical devices.
Guangbaishan said that in the next five years, medical devices and diagnostic reagents will become one of the three new formats that the Group will focus on and build. By attracting capital (resources) and attracting talents (talents), they will aim at the international stage in the initial stage of industrial layout. The road to transformation has been cut into the field through various means such as international cooperation, mergers and acquisitions, and equity participation.
Diversified development of categories
In addition, Wang Lao Ji Da Health Industry Co., Ltd., a subsidiary of Baiyun Mountain, signed a contract with Shanxi Dazhai Beverage Co., Ltd., and the two parties intend to establish a joint venture company, which is controlled by Wang Laoji Health Company to develop the market of walnut dew beverage. This is the first investment project of Wang Lao Ji Da Health, officially entered the protein beverage market, and achieved rapid development of product diversification.
It is understood that Shanxi Dazhai Beverage Company owns 1,500 acres of walnut planting base. As the fruit-hanging rate of the base walnuts increases year by year, the cost advantage becomes increasingly obvious.
The joint venture company will have the brand, raw material area and product advantages of Dazhai Beverage Co., Ltd., and also cover Wang Laoji's channel resource capacity and brand marketing layout advantages.
According to the person in charge of Wang Laoji, the two sides will strengthen the effective integration and utilization of resources and form an industrial docking advantage, which will become a new profit growth point for the company. According to estimates, the current sales of Dazhai Walnut is about 300 million yuan, and cooperation between the two parties is expected to further expand the market share of products.
It is worth noting that the joint venture company's operation team will hold shares to encourage the Dazhai Walnut Project to accelerate development, and it is expected to become the first “mixed and modified†project of GPHL.
Puyang Linshi Medical Supplies Co., Ltd. , https://www.linshihealths.com